Global Self Glucose Monitoring Market Size By Type (Blood Glucose Meter, Blood Glucose Testing Strips), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Self Glucose Monitoring Market Report Description

The Global Self Glucose Monitoring (SGM) Market was valued at USD 12.3 billion in 2023 and is projected to reach USD 21.4 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2023–2031). The market growth is primarily driven by the increasing prevalence of diabetes, rising health awareness, and the advancements in portable glucose monitoring technologies. Self glucose monitoring devices are crucial for effective diabetes management, enabling patients to measure and track their blood glucose levels conveniently, thereby reducing long-term complications and improving quality of life.

The market is witnessing strong momentum due to the shift toward minimally invasive and continuous glucose monitoring systems (CGM), integration of smartphone connectivity, and the growing adoption of digital health platforms for real-time data sharing and analysis.

Drivers

Rising Global Diabetes Prevalence

With over 537 million adults living with diabetes globally (as per the IDF 2023 report), the need for efficient self-monitoring solutions is increasing. Early detection and regular monitoring are essential for better glycemic control, driving demand for advanced SGM devices.

Technological Advancements in Glucose Monitoring

Innovations such as continuous glucose monitoring (CGM), smart wearables, and non-invasive glucose monitoring systems are enhancing patient convenience and compliance, fueling market growth.

Shift Towards Home-based Healthcare

The post-pandemic emphasis on remote patient monitoring and home healthcare solutions has boosted the adoption of self glucose monitoring devices, reducing dependency on frequent clinical visits.

Restraints

High Cost of Advanced CGM Devices

While basic glucose meters are affordable, advanced CGM systems remain expensive, limiting adoption among low-income populations and in developing economies.

Accuracy and Calibration Challenges

Despite technological improvements, some non-invasive and wearable glucose monitors face accuracy concerns, which may reduce patient trust and adoption.

Opportunity

Expansion in Emerging Markets

Rapid urbanization, rising healthcare awareness, and increasing healthcare spending in Asia-Pacific and Latin America present significant growth opportunities for SGM device manufacturers.

Integration with Digital Health Ecosystems

Combining glucose monitoring with AI-driven analytics, mobile health apps, and telemedicine platforms can create new value-added services, enabling personalized diabetes care.

Development of Non-invasive Technologies

The demand for needle-free glucose monitoring solutions is creating opportunities for R&D investments and new product launches.

Market by System Type Insights

Blood Glucose Meters (BGM) dominated the market in 2023 due to their affordability, ease of use, and wide availability.

Continuous Glucose Monitoring (CGM) devices are expected to witness the fastest growth as patients increasingly prefer real-time data, alerts, and integration with insulin pumps and smartphones.

Market by End-use Insights

The Homecare segment accounted for the largest share in 2023, driven by the rising adoption of self-monitoring practices and the preference for convenient at-home diabetes management.

The Hospitals & Clinics segment is expected to grow steadily due to the rising need for periodic monitoring and diabetes management programs.

Market by Regional Insights

North America held the largest market share in 2023 due to a high diabetes prevalence, strong reimbursement policies, and the presence of major industry players.

Asia-Pacific is projected to grow at the highest CAGR, fueled by a rapidly increasing diabetic population in countries like China and India, improving healthcare infrastructure, and rising awareness.

Europe remains a key market driven by robust healthcare systems and favorable government initiatives for diabetes management.

Competitive Scenario

Key players operating in the Global Self Glucose Monitoring Market include:

Abbott Laboratories

Roche Diagnostics

Dexcom, Inc.

Medtronic plc

Ascensia Diabetes Care

LifeScan, Inc.

Senseonics Holdings, Inc.

B. Braun Melsungen AG

These companies focus on product innovation, partnerships with digital health platforms, and geographical expansion. For instance:

In 2023, Abbott launched a new CGM system with enhanced smartphone integration and longer sensor wear duration.

In 2024, Dexcom announced a partnership with a telehealth platform to provide real-time glucose insights for remote diabetes management.

In 2025, Roche introduced a non-invasive wearable glucose sensor designed for continuous monitoring.

Scope of Work – Global Self Glucose Monitoring Market

Key Market Developments

2023: Abbott launched its next-generation FreeStyle Libre CGM with improved accuracy and extended wear time.

2024: Dexcom partnered with AI-driven diabetes management platforms to offer predictive analytics for better glucose control.

2025: Medtronic announced the world’s smallest implantable glucose sensor, reducing the need for frequent replacements.

FAQs

1. What is the current market size of the Global Self Glucose Monitoring Market?

The market was valued at USD 12.3 billion in 2023.

2. What is the major growth driver of the Global Self Glucose Monitoring Market?

The primary driver is the rising global prevalence of diabetes and the increasing adoption of advanced CGM devices for better glucose control.

3. Which is the largest region during the forecast period in the Global Self Glucose Monitoring Market?

North America holds the largest market share, while Asia-Pacific is expected to witness the highest growth.

4. Which segment accounted for the largest market share in the Global Self Glucose Monitoring Market?

The Blood Glucose Meters (BGM) segment held the largest share in 2023, but CGM devices are expected to grow fastest.

5. Who are the key market players in the Global Self Glucose Monitoring Market?

Key players include Abbott Laboratories, Dexcom, Roche Diagnostics, Medtronic, and Ascensia Diabetes Care.

Would you like me to generate a visually formatted PDF of this report for easier sharing and presentation?